PROCEPT BioRobotics Corporation PRCT Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

Intuitive SurgicalISRG

——

UFP TechnologiesUFPT

——

iRadimedIRMD

——

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$83.1M+20.2%

Gross profit$53.9M+22.2%

Operating income-$32.6M-18.8%

Net income-$31.6M-27.9%

EPS (diluted)-$0.56-24.4%

Balance sheet

See full

Cash & equivalents$12.2M-96.2%

Total debt$78.0M-11.8%

Total equity$347.7M-10.7%

Total assets$487.1M-6.2%

Cash flow

See full

Operating cash flow-$38.1M-125%

CapEx$2.9M+58.7%

Free cash flow-$41.0M-118%

Valuation

See full

Market cap$1.19B-24.8%

Enterprise value$1.25B—

P/S3.7×—

Profitability

See full

Gross margin64%+1.3pp

Operating margin-33.9%-3.8pp

Net margin-31.8%-3.4pp

FCF margin-25%-5.7pp

Returns & leverage

See full

Return on equity-27.8%+0.2pp

Debt / equity0.2×0.0×

Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's remainder of fiscal year 2024?: PROCEPT BioRobotics Corporation (PRCT) reported remainder of fiscal year 2024 of $3.32M in Q1 2026.
How has PROCEPT BioRobotics Corporation's remainder of fiscal year 2024 changed year-over-year?: PROCEPT BioRobotics Corporation's remainder of fiscal year 2024 increased by 3.0% year-over-year, from $3.22M to $3.32M.